Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

ExCeL London, Royal Victoria Dock, 1 Western Gateway, London E16 1XL

  1. Events
  2. Venues
  3. ExCeL London, Royal Victoria Dock, 1 Western Gateway, London E16 1XL
Events at this venue
Today

Advanced Therapies Congress

Europe's largest cell and gene therapy conference and exhibition brings together senior leaders from pioneering ATMP companies, exploring the latest technologies and strategies shaping the [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top